Published On: 10/29/2024
DIA RWE 2024 Research: Presentation by David Pritchard, PhD
Target RWE Director of Data Management & Statistics, David Pritchard, PhD, recently provided an insightful video preview of his presentation at the DIA Real-World Evidence (RWE) Conference titled 'Making the Case for Negative Control Outcome Studies in a Real-World Evidence Setting.' In this session, Dr. Pritchard delves into using Negative Control Outcome studies (NCOs) as a methodological approach to ensure robust treatment group comparability, ultimately strengthening study validity and reliability in real-world research settings.
Watch the video below to gain a deeper understanding of how NCO studies can enhance the accuracy of your research, reduce bias, and elevate the overall quality of your study findings.
About Target RWE
Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.
Visit our website to learn more: https://targetrwe.com/
Contact:
McKinley Peter
Digital Marketing Specialist
+1 (352) 514-8045
More News
-
05/09/2025
Target RWE at EASL 2025: Advancing HCC, MASH & PBC Research -
05/08/2025
EASL 2025 Research: Presentation by Michael Roden, MD -
04/25/2025
How does causalStudio™ address the key regulatory requirements for data integrity, traceability, and analysis? -
04/03/2025
An Overview of MASH: Advancements in Diagnosis, Treatment, and the Role of Real-World Data -
03/31/2025
Addressing the Burden of Hidradenitis Suppurativa: The Often-Hidden Impact on Quality of Life